A woman in Costa Rica developed cold agglutinin disease (CAD) secondary to a diagnosis of systemic lupus erythematosus (SLE)…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A Japanese woman developed cold agglutination disease (CAD) following COVID-19 and a secondary bacterial infection in the lungs that…
Vermont Governor Phil Scott has signed into law a bill that improves access to the right medication at the right…
A woman with both cold agglutinin disease (CAD) and myelodysplastic syndrome, a rare blood cancer, responded well to treatment…
Daratumumab, given on its own, could be a treatment for adults with hard to treat cold agglutinin disease (CAD),…
Cold agglutinin disease (CAD) secondary to a blood cancer was the most likely diagnosis for an elderly woman in…
Cold agglutinin disease (CAD) secondary to an infection with the Epstein-Barr virus led to a blocked vein due to…
People with cold agglutinin disease (CAD) who were on Enjaymo (sutimlimab-jome) during clinical trials produced antibodies in response…
A young boy in Portugal developed cold agglutinin disease (CAD) and an inflammatory condition called hemophagocytic lymphohistiocytosis (HLH) secondary…
While cold agglutinin disease (CAD) may vary widely in severity and course, more than half of patients experience symptoms…